BCR and chronic myelogenous leukemia, BCR-ABL1 positive: We have some knowledge of PP2A role in CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) thanks in large part to the work of the Perrotti group in their studies on BCR–ABL regulation of PP2A in these diseases (18–23).